RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway

The Journal of Immunology : Official Journal of the American Association of Immunologists
A DebB R Williams

Abstract

The IFN-inducible dsRNA-activated protein kinase PKR regulates protein synthesis through phosphorylation of eukaryotic initiation factor-2alpha. It also acts as a signal transducer for transcription factors NF-kappaB, IFN regulatory factor-1, and activating transcription factor-2. IFN-gamma, a pleiotropic cytokine, elicits gene expression by activating the Janus kinase-STAT signaling pathway. IFN-gamma can synergize with TNF-alpha to activate NF-kappaB in a number of cell lines. Here we show that IFN-gamma alone can activate NF-kappaB, by a Janus kinase-1-mediated, but Stat1-independent, mechanism. NF-kappaB activation by IFN-gamma is associated with degradation of IkappaB beta. The IFN-gamma response can be blocked by 2',5'-oligoadenylate-linked antisense chimeras against PKR mRNA. There was no activation of NF-kappaB by IFN in PKR-null cells, indicating that PKR is required for IFN-gamma signaling to NF-kappaB.

References

Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·T ItoW S May
Jan 1, 1995·Advances in Immunology·E B Kopp, S Ghosh
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·A KumarB R Williams
Jan 1, 1994·Annual Review of Immunology·P A Baeuerle, T Henkel
Jan 1, 1996·Annual Review of Immunology·A S Baldwin
Dec 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·P D DrewK Ozato
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·N M CirinoR H Silverman
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·S D DerB R Williams
Jan 1, 1997·Annual Review of Immunology·U BoehmJ C Howard
May 1, 1997·Biochemical Society Transactions·B R Williams
Sep 12, 1997·Science·J E Darnell
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·I M Verma, J Stevenson
Nov 14, 1997·The American Journal of Physiology·S D SavkovicG Hecht
Mar 24, 1998·Immunology Today·M J May, S Ghosh
May 23, 1998·Annual Review of Immunology·S GhoshE B Kopp
Aug 4, 1998·The EMBO Journal·R C Patel, G C Sen
Aug 26, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·P T Massa, C Wu
Oct 6, 1998·Annual Review of Biochemistry·G R StarkR D Schreiber
Feb 2, 1999·Oncogene·M Zamanian-DaryoushB R Williams
Nov 11, 1999·Oncogene·B R Williams
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S K BandyopadhyayB R Williams

❮ Previous
Next ❯

Citations

Nov 26, 2003·The American Journal of Gastroenterology·Yoichi HiasaRaymond T Chung
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dayna J GroskreutzGary W Hunninghake
Dec 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ying HuangSeng-Lai Tan
Dec 13, 2006·Microbiology and Molecular Biology Reviews : MMBR·M A GarcíaM Esteban
Sep 10, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jennifer M ReedAnil Bamezai
Apr 16, 2009·Clinical Microbiology Reviews·Trine H Mogensen
Jun 3, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Lawrence M Pfeffer
Apr 28, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jutta Horejs-HoeckAlbert Duschl
Apr 11, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Siddharth Balachandran, Gregory P Adams
Jul 17, 2003·The Journal of Clinical Investigation·Gregory B LesinskiWilliam E Carson
Dec 3, 2002·Nature Reviews. Cancer·E Antonio Chiocca
Feb 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael D RobekFrancis V Chisari
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cheng-Chieh TsaiChiou-Feng Lin
Nov 1, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·David B ShultzGeorge R Stark
May 18, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Maria A BlahoianuAshok Kumar
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nywana SizemoreGeorge R Stark
Jul 2, 2003·The Journal of Experimental Medicine·Ursula GrohmannPaolo Puccetti
Dec 26, 2001·Science's STKE : Signal Transduction Knowledge Environment·B R Williams
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Duane R Wesemann, Etty N Benveniste
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sujan ShrestaEva Harris
May 18, 2011·Molecular and Cellular Biology·Roshan J ThapaSiddharth Balachandran
May 22, 2018·Frontiers in Immunology·Flávia CastroMaria José Oliveira
May 11, 2018·Journal of Gastroenterology and Hepatology·Satoshi YasudaHidemi Goto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis